Visioneering Technologies (ASX:VTI) ROE % Adjusted to Book Value : -42.97% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies ROE % Adjusted to Book Value?

Visioneering Technologies's ROE % for the quarter that ended in Dec. 2023 was -64.02%. Visioneering Technologies's PB Ratio for the quarter that ended in Dec. 2023 was 1.49. Visioneering Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -42.97%.

Visioneering Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for Visioneering Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies ROE % Adjusted to Book Value Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-18.05

-37.69

-55.41

-38.60

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-11.46	-117.49	-61.13	-57.00	-42.97

Competitive Comparison of Visioneering Technologies's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Visioneering Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visioneering Technologies's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's ROE % Adjusted to Book Value falls into.

Visioneering Technologies ROE % Adjusted to Book Value Calculation

Visioneering Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-57.51%	/	1.49
	=	-38.60%

Visioneering Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-64.02%	/	1.49
	=	-42.97%

Visioneering Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies (ASX:VTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.